{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T05:55:44Z","timestamp":1793858144511,"version":"4.6.1"},"reference-count":41,"publisher":"Pleiades Publishing Ltd","issue":"1","license":[{"start":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T00:00:00Z","timestamp":1746921600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T00:00:00Z","timestamp":1746921600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dokl Biochem Biophys"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1134\/s1607672925700152","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T10:27:50Z","timestamp":1747045670000},"page":"375-386","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Thrombotic Antiphospholipid Syndrome: Recurrent Thromboses"],"prefix":"10.1134","volume":"522","author":[{"given":"T. M.","family":"Reshetnyak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. A.","family":"Cheldieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. I.","family":"Glukhova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. S.","family":"Nurbaeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. V.","family":"Seredavkina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. V.","family":"Cherkasova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. M.","family":"Lila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. L.","family":"Nasonov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"137","published-online":{"date-parts":[[2025,5,11]]},"reference":[{"key":"7684_CR1","first-page":"56","volume":"52","author":"T.M. Reshetnyak","year":"2014","unstructured":"Reshetnyak, T.M., Antiphospholipid syndrome: diagnosis and clinical manifestations (lecture), Nauchno-Prakt. Revmatol., 2014, vol. 52, no. 2, pp. 56\u201371.","journal-title":"Nauchno-Prakt. Revmatol."},{"key":"7684_CR2","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S. Miyakis","year":"2006","unstructured":"Miyakis, S., Lockshin, M.D., Atsumi, T., Branch, D.W., Brey, R.L., et al., International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS), J. Thromb. Haemost., 2006, vol. 4, no. 2, pp. 295\u2013306.","journal-title":"J. Thromb. Haemost."},{"key":"7684_CR3","volume-title":"Antifosfolipidny sindrom (Antiphospholipid Syndrome)","year":"2004","unstructured":"Antifosfolipidny sindrom (Antiphospholipid Syndrome), Nasonov, E.L., Ed., Moscow: Litterra, 2004."},{"key":"7684_CR4","first-page":"4","volume":"4","author":"T.M. Reshetnyak","year":"2020","unstructured":"Reshetnyak, T.M., Cheldieva, F.A., Nurbaeva, K.S., Lila, A.M., and Nasonov, E.L., Antiphospholipid syndrome: diagnosis, mechanism of development, therapy issues, Tromboz, \n               Hemostaz Reol., 2020, vol. 4, pp. 4\u201321.","journal-title":"Hemostaz Reol."},{"key":"7684_CR5","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1177\/0961203315617538","volume":"25","author":"M. Bazzan","year":"2016","unstructured":"Bazzan, M., Vaccarino, A., Stella, S., Sciascia, S., Montaruli, B., et al., Piedmont APS Consortium, Patients with antiphosholipid syndrome and thrombotic recurrences: a real world observation (the Piedmont cohort study), Lupus, 2016, vol. 25, no. 5, pp. 479\u2013485.","journal-title":"Lupus"},{"key":"7684_CR6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1177\/0961203310396748","volume":"20","author":"R.L. Brey","year":"2011","unstructured":"Brey, R.L., Muscal, E., and Chapman, J., Antiphospholipid antibodies and the brain: a consensus report, Lupus, 2011, vol. 20, no. 2, pp. 153\u2013157.","journal-title":"Lupus"},{"key":"7684_CR7","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1136\/annrheumdis-2019-215213","volume":"78","author":"M.G. Tektonidou","year":"2019","unstructured":"Tektonidou, M.G., Andreoli, L., Limper, M., Amoura, Z., Cervera, R., et al., EULAR recommendations for the management of antiphospholipid syndrome in adults, Ann. Rheum. Dis., 2019, vol. 78, no. 10, pp.\u00a01296\u20131304.","journal-title":"Ann. Rheum. Dis."},{"key":"7684_CR8","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.3899\/jrheum.161364","volume":"44","author":"M. Taraborelli","year":"2017","unstructured":"Taraborelli, M., Reggia, R., Dall\u2019Ara, F., Fredi, M., Andreoli, L., et al., Longterm outcome of patients with primary antiphospholipid syndrome: a retrospective multicenter study, J. Rheumatol., 2017, vol. 44, no. 8, pp. 1165\u20131172.","journal-title":"J. Rheumatol."},{"key":"7684_CR9","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1182\/bloodadvances.2017008185","volume":"1","author":"W.G. Jackson","year":"2017","unstructured":"Jackson, W.G., Oromendia, C., Unlu, O., Erkan, D., and DeSancho, M.T., Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking, Recurrent thrombosis in patients with antiphospholipid antibodies and arterial thrombosis on antithrombotic therapy, Blood Adv., 2017, vol. 1, no. 25, pp. 2320\u20132324.","journal-title":"Blood Adv."},{"key":"7684_CR10","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1093\/rheumatology\/kes388","volume":"52","author":"S. Sciascia","year":"2013","unstructured":"Sciascia, S., Sanna, G., Murru, V., Roccatello, D., Khamashta, M.A., et al., GAPSS: The Global Anti-Phospholipid Syndrome Score, Rheumatology, 2013, vol. 52, no. 8, pp. 1397\u20131403.","journal-title":"Rheumatology"},{"key":"7684_CR11","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ijcard.2017.02.155","volume":"240","author":"M. Radin","year":"2017","unstructured":"Radin, M., Schreiber, K., Costanzo, P., Cecchi, I., Roccatello, D., et al., The Adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) for risk stratification in young APS patients with acute myocardial infarction, Int. J. Cardiol., 2017, vol. 240, pp. 72\u201377.","journal-title":"Int. J. Cardiol."},{"key":"7684_CR12","first-page":"546","volume":"60","author":"F.A. Cheldieva","year":"2022","unstructured":"Cheldieva, F.A., Reshetnyak, T.M., Shumilova, A.A., Nurbaeva, K.S., Cherkasova, M.V., et al., General antiphospholipid syndrome score (GAPSS) in patients with systemic lupus erythematosus, Nauchno-Prakt. Revmatol., 2022, vol. 60, no. 5, pp. 546\u2013553.","journal-title":"Nauchno-Prakt. Revmatol."},{"key":"7684_CR13","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.1538-7836.2009.03674.x","volume":"8","author":"V. Pengo","year":"2010","unstructured":"Pengo, V., Ruffatti, A., Legnani, C., Gresele, P., Barcellona, D., et al., Clinical course of high-risk patients diagnosed with antiphospholipid syndrome, J. Thromb. Haemost., 2010, vol. 8, no. 2, pp. 237\u2013242.","journal-title":"J. Thromb. Haemost."},{"key":"7684_CR14","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1182\/blood-2002-02-0441","volume":"101","author":"M. Galli","year":"2003","unstructured":"Galli, M., Luciani, D., Bertolini, G., and Barbui, T., Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature, Blood, 2003, vol. 101, no. 5, pp. 1827\u20131832.","journal-title":"Blood"},{"key":"7684_CR15","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1002\/acr.22066","volume":"65","author":"L. Andreoli","year":"2013","unstructured":"Andreoli, L., Chighizola, C.B., Banzato, A., Pons-Estel, G.J., Ramire de Jesus, G., et al., Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature, Arthritis Care Res. (Hoboken), 2013, vol. 65, no. 11, pp. 1869\u20131873.","journal-title":"Arthritis Care Res."},{"key":"7684_CR16","doi-asserted-by":"publisher","first-page":"997","DOI":"10.7326\/0003-4819-117-12-997","volume":"117","author":"K.S. Ginsburg","year":"1992","unstructured":"Ginsburg, K.S., Liang, M.H., Newcomer, L., Goldhaber, S.Z., and Schur, P.H., Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis, Ann. Intern. Med., 1992, vol. 117, no. 12, pp.\u00a0997\u20131002.","journal-title":"Ann. Intern. Med."},{"key":"7684_CR17","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1001\/jama.291.5.576","volume":"291","author":"S.R. Levine","year":"2004","unstructured":"Levine, S.R., Brey, R.L., Tilley, B.C., Thompson, J.L., and Sacco, R.L., APASS Investigators, Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke, JAMA, 2004, vol. 291, no. 5, pp. 576\u2013584.","journal-title":"JAMA"},{"key":"7684_CR18","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1161\/01.STR.0000117575.48205.2D","volume":"35","author":"V. Janardhan","year":"2004","unstructured":"Janardhan, V., Wolf, P.A., Kase, C.S., Massaro, J.M., D\u2019Agostino, R.B., et al., Anticardiolipin antibodies and risk of ischemic stroke and transient ischemic attack: the Framingham cohort and offspring study, Stroke, 2004, vol. 35, no. 3, pp. 736\u2013741.","journal-title":"Stroke"},{"key":"7684_CR19","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1161\/CIRCULATIONAHA.114.012479","volume":"131","author":"Z. Arvanitakis","year":"2015","unstructured":"Arvanitakis, Z., Brey, R.L., Rand, J.H., Schneider, J.A., Capuano, A.W., et al., Relation of antiphospholipid antibodies to postmortem brain infarcts in older people, Circulation, 2015, vol. 131, no. 2, pp. 182\u2013189.","journal-title":"Circulation"},{"key":"7684_CR20","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1159\/000360473","volume":"6","author":"P. Anand","year":"2014","unstructured":"Anand, P., Mann, S.K., Fischbein, N.J., and Lansberg, M.G., Bilateral internal carotid artery occlusion associated with the antiphospholipid antibody syndrome, Case Rep. Neurol., 2014, vol. 6, no. 1, pp. 50\u201354.","journal-title":"Case Rep. Neurol."},{"key":"7684_CR21","first-page":"172","volume":"12","author":"M. Etemadifar","year":"2013","unstructured":"Etemadifar, M., Dehghani, L., Tahani, S., Toghianifar, N., and Rahaimi, M., Neurological manifestations in patients with antiphospholipid syndrome, Iran. J. Neurol., 2013, vol. 12, no. 4, pp. 172\u2013175.","journal-title":"Iran. J. Neurol."},{"key":"7684_CR22","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"M.C. Hochberg","year":"1997","unstructured":"Hochberg, M.C., Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus, Arthritis Rheum., 1997, vol. 40, no. 9, p. 1725.","journal-title":"Arthritis Rheum."},{"key":"7684_CR23","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/art.34473","volume":"64","author":"M. Petri","year":"2012","unstructured":"Petri, M., Orbai, A.M., Alarc\u00f3n, G.S., Gordon, C., Merrill, J.T., et al., Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus, Arthritis Rheum., 2012, vol. 64, no. 8, pp. 2677\u20132686.","journal-title":"Arthritis Rheum."},{"key":"7684_CR24","doi-asserted-by":"publisher","first-page":"81","DOI":"10.14412\/1996-7012-2022-2-81-86","volume":"16","author":"T.M. Reshetnyak","year":"2022","unstructured":"Reshetnyak, T.M., Cheldieva, F.A., Cherkasova, M.V., and Lila, A.M., Clinical significance of antibodies to the phosphatidylserine\/prothrombin complex, Sovrem. Revmatol., 2022, vol. 16, no. 2, pp. 81\u201386.","journal-title":"Sovrem. Revmatol."},{"key":"7684_CR25","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1002\/art.42624","volume":"75","author":"M. Barbhaiya","year":"2023","unstructured":"Barbhaiya, M., Zuily, S., Naden, R., Hendry, A., Manneville, F., et al., The 2023 ACR\/EULAR antiphospholipid syndrome classification criteria, Arthritis Rheumatol., 2023, vol. 75, no. 10, pp. 1687\u20131702.","journal-title":"Arthritis Rheumatol."},{"key":"7684_CR26","doi-asserted-by":"crossref","unstructured":"Zhang, S., Wu, Z., Li, P., Bai, Y., Zhang, F., et al., Evaluation of the clinical performance of a novel chemiluminescent immunoassay for detection of anticardiolipin and anti-beta2-glycoprotein 1 antibodies in the diagnosis of antiphospholipid syndrome, Medicine (Baltimore), 2015, vol. 94, no. 46, p. e2059.","DOI":"10.1097\/MD.0000000000002059"},{"key":"7684_CR27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.5152\/eurjrheum.2015.0085","volume":"3","author":"O. \u00dcnl\u00fc","year":"2016","unstructured":"\u00dcnl\u00fc, O., Zuily, S., and Erkan, D., The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus, Eur. J. Rheumatol., 2016, vol. 3, no. 2, pp. 75\u201384.","journal-title":"Eur. J. Rheumatol."},{"key":"7684_CR28","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1136\/annrheumdis-2019-215213","volume":"78","author":"M.G. Tektonidou","year":"2019","unstructured":"Tektonidou, M.G., Andreoli, L., Limper, M., Amoura, Z., Cervera, R., et al., EULAR recommendations for the management of antiphospholipid syndrome in adults, Ann. Rheum. Dis., 2019, vol. 78, no. 10, pp.\u00a01296\u20131304.","journal-title":"Ann. Rheum. Dis."},{"key":"7684_CR29","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1182\/blood-2017-09-805689","volume":"131","author":"C. Kearon","year":"2018","unstructured":"Kearon, C., Parpia, S., Spencer, F.A., Baglin, T., and Stevens, S.M., Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism, Blood, 2018, vol. 131, no. 19, pp. 2151\u20132160.","journal-title":"Blood"},{"key":"7684_CR30","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.1538-7836.2009.03674.x","volume":"8","author":"V. Pengo","year":"2010","unstructured":"Pengo, V., Ruffatti, A., Legnani, C., Gresele, P., Barcellona, D., et al., Clinical course of high-risk patients diagnosed with antiphospholipid syndrome, J. Thromb. Haemost., 2010, vol. 8, no. 2, pp. 237\u2013242.","journal-title":"J. Thromb. Haemost."},{"key":"7684_CR31","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1002\/art.42624","volume":"75","author":"M. Barbhaiya","year":"2023","unstructured":"Barbhaiya, M., Zuily, S., Naden, R., Hendry, A., Manneville, F., et al., ACR\/EULAR APS Classification Criteria Collaborators, The 2023 ACR\/EULAR Antiphospholipid Syndrome Classification Criteria, Arthritis Rheumatol., 2023, vol. 75, no. 10, pp. 1687\u20131702.","journal-title":"Arthritis Rheumatol."},{"key":"7684_CR32","doi-asserted-by":"publisher","first-page":"475","DOI":"10.37349\/ei.2023.00114","volume":"3","author":"F.A. Cheldieva","year":"2023","unstructured":"Cheldieva, F.A., Shumilova, A.A., Cherkasova, M.V., Glukhova, S.I., Lila, A.M., et al., Risk factors and recurrent thrombosis in primary antiphospholipid syndrome, Explor. Immunol., 2023, vol. 3, no. 5, pp. 475\u2013489.","journal-title":"Explor. Immunol."},{"key":"7684_CR33","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11926-020-00901-y","volume":"22","author":"V. Dufrost","year":"2020","unstructured":"Dufrost, V., Darnige, L., Reshetnyak, T., Vorobyeva, M., Jiang, X., et al., New insights into the use of direct oral anticoagulants in non-high risk thrombotic APS patients: literature review and subgroup analysis from a meta-analysis, Curr. Rheumatol. Rep., 2020, vol. 22, p.\u00a025.","journal-title":"Curr. Rheumatol. Rep."},{"key":"7684_CR34","first-page":"16","volume":"25","author":"R.C.R. Correa","year":"2018","unstructured":"Correa, R.C.R., Franco, C.J.V., Mu\u00f1oz-Grajales, C., Pe\u00f1aranda, L.F.P., Hern\u00e1ndez, J.D., et al., Use of factor Xa inhibitors in antiphospholipid antibodies syndrome: a series of seven cases, Rev. Colomb. Reumatol., 2018, vol. 25, no. 1, pp. 16\u201321.","journal-title":"Rev. Colomb. Reumatol."},{"key":"7684_CR35","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.autrev.2018.04.009","volume":"17","author":"V. Dufrost","year":"2018","unstructured":"Dufrost, V., Risse, J., Reshetnyak, T., Satybaldyeva, M., Du, Y., et al., Increased risk of thrombosis in antiphospholipid syndrome patients treated with direct oral anticoagulants. Results from an international patient-level data meta-analysis, Autoimmun. Rev., 2018, vol.\u00a017, no.\u00a010, pp. 1011\u20131021.","journal-title":"Autoimmun. Rev."},{"key":"7684_CR36","doi-asserted-by":"publisher","first-page":"152","DOI":"10.17116\/flebo202317031152","volume":"17","author":"E.I. Selivestrov","year":"2023","unstructured":"Selivestrov, E.I., Lobastov, K.V., Iluhin, E.A., Apkhanova, T.V., Akhmetzyanov, R.V., et al., Prevention, diagnosis and treatment of deep vein thrombosis. Recommendations of Russian experts, Flebologiya, 2023, vol. 17, no. 3, pp. 152\u2013296.","journal-title":"Flebologiya"},{"key":"7684_CR37","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1177\/1076029617727859","volume":"24","author":"D. Navarro-Carpentieri","year":"2018","unstructured":"Navarro-Carpentieri, D., Del Carmen Castillo-Hernandez, M., Majluf-Cruz, K., Espejo-Godinez, G., Carmona-Olvera, P., Moreno-Hernandez, M., Lugo-Garc\u00eda, Yo., Hernandez-Juarez, J., Loarca-Pi\u00f1a, L., Isordia-Salas, I., and Majluf-Cruz, A., Impact of classical risk factors for arterial or venous thrombosis in patients with antiphospholipid syndrome, Clin. Appl. Thrombosis\/Hemostasis, 2018, vol. 24, no. 5, pp. 834\u2013840. https:\/\/doi.org\/10.1177\/1076029617727859","journal-title":"Clin. Appl. Thrombosis\/Hemostasis"},{"key":"7684_CR38","first-page":"60","volume":"80","author":"T.M. Reshetnyak","year":"2008","unstructured":"Reshetnyak, T.M., Seredavkina, N.V., Mach, E.S., Alexandrova, E.N., Novikov, A.A., et al., Subclinical and clinical manifestations of atherosclerosis in antiphospholipid syndrome, Ter. Arkh., 2008, vol. 80, no. 10, pp.\u00a060\u201367.","journal-title":"Ter. Arkh."},{"key":"7684_CR39","unstructured":"German, H., Ugarte-Gil, M.F., Espinosa, G., T\u00e0ssies, D., Monteagudo, J., et al., Can inherited thrombophilia modulate the clinical phenotype of patients with antiphospholipid syndrome?, Clin. Exp. Rheumatol., 2013, vol. 31, no. 6, pp. 926\u2013932."},{"key":"7684_CR40","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s11239-009-0356-9","volume":"29","author":"R. Diz-Kucukkaya","year":"2010","unstructured":"Diz-Kucukkaya, R., Hancer, V.S., Artim-Esen, B., Pekcelen, Y., and Inanc, M., The prevalence and clinical significance of inherited thrombophilic risk factors in patients with antiphospholipid syndrome, J. Thromb. Thrombolysis, 2010, vol. 29, no. 3, pp. 303\u2013309.","journal-title":"J. Thromb. Thrombolysis"},{"key":"7684_CR41","first-page":"34","volume":"72","author":"T.M. Reshetnyak","year":"2000","unstructured":"Reshetnyak, T.M., Patrushev, M.I., Stukacheva, E.A., Miroshnikov, A.I., Tikhonova, T.L., et al., G20210A mutations in the prothrombin gene and antiphospholipid antibodies in systemic lupus erythematosus and antiphospholipid syndrome, Ter. Arkh., 2000, vol. 72, no. 5, pp. 34\u201338.","journal-title":"Ter. Arkh."}],"container-title":["Doklady Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S1607672925700152.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1134\/S1607672925700152","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S1607672925700152.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T15:24:10Z","timestamp":1773761050000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1134\/S1607672925700152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,11]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["7684"],"URL":"https:\/\/doi.org\/10.1134\/s1607672925700152","relation":{},"ISSN":["1607-6729","1608-3091"],"issn-type":[{"value":"1607-6729","type":"print"},{"value":"1608-3091","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,11]]},"assertion":[{"value":"3 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the local ethics committee (protocol no. 25 of December 23, 2021). All patients were observed at the Nasonova Research Institute of Rheumatology and underwent standard clinical, laboratory, and instrumental examination recommended by the Association of Rheumatologists of Russia. All patients signed informed consent to participate in the study. Laboratory examination included a general clinical blood test, biochemical blood test, and general urine test.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"ETHICS APPROVAL AND CONSENT TO PARTICIPATE"}},{"value":"The authors of this work declare that they have no conflicts of interest. The authors bear full responsibility for submitting the final version of the manuscript for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"CONFLICT OF INTEREST"}}]}}